drugset / Trial / NCT02632760

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery

NCT02632760

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomised double-blind, controlled phase IV trial will compare the efficacy, safety and cost-effectiveness of preoperative IV iron with placebo in patients with anaemia before elective cardiac surgery.

Timeline

Start
2016-07-15
Primary completion
2024-04-16
Completion
2024-11-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferric carboxymaltose Other / unclassified 1000 mg Intravenous
Subject Iron isomaltoside 1000 Unknown 1000 mg Intravenous

Indications